ベアメタルステント市場：製品別、エンドユーザー別-2025-2030年の世界予測

ベアメタルステント市場は、2023年に62億3,000万米ドルと評価され、2024年には65億7,000万米ドルに達すると予測され、CAGR 5.66%で成長し、2030年には91億7,000万米ドルに達すると予測されています。

ベアメタルステントは、冠動脈疾患患者の狭窄または閉塞した冠動脈を治療するために使用される医療機器です。血管形成術後の動脈閉鎖に対抗するための足場として機能し、血流を促進し、再狭窄を予防します。ベアメタルステントの必要性と応用は、心血管疾患の症例が増加する高齢化社会において極めて重要であり、多くの場合、コストの削減と、長期の二重抗血小板療法を受けることができない患者への特異的な適合性が特徴です。最終用途は病院、外来手術センター、心臓カテーテル検査室など多岐にわたるが、これらのステントは薬剤溶出性ステントに比べて即座に入手でき、挿入が容易なことから好まれています。有力な成長促進要因としては、ヘルスケアインフラの拡大、老人人口の増加、世界中で増加する心臓関連疾患などが挙げられます。この市場には、医療制度が急速に改善しつつある新興市場での地理的拡大とともに、柔軟性を高め血栓率を低下させるためのステント材料の改良というビジネスチャンスがあります。こうした機会を活用するため、企業は費用対効果の高いステントモデルの開発に注力し、臨床転帰を改善するための研究開発に投資することができます。しかし、規制当局の承認が厳しく、再狭窄率が低い薬剤溶出ステントの人気が高まっており、ベアメタル型ステントの影が薄くなりかねないという課題も残っています。市場参入企業は、生分解性材料や、ベアメタルと薬剤溶出ステントの両方の利点を併せ持つハイブリッドステントデザインに注目することで、技術革新を推進することができます。さらに、3Dプリンティングのような高度な製造技術を活用することで、ステント配備におけるカスタマイズ性と精度を高めることができます。市場の競争は、製品の信頼性と受容性を高めるための戦略的パートナーシップと厳格な臨床試験の重要性を強調しています。全体として、規制状況を効果的にナビゲートしながら、素材の革新と世界市場への浸透を図ることで、事業の大幅な成長を達成することができます。

市場力学：急速に進化するベアメタルステント市場の主要市場インサイトを公開

ベアメタルステント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の心血管疾患（CVD）の増加
  • 低侵襲治療への嗜好の高まり
• 市場抑制要因
  • 市場における代替治療の利用可能性
• 市場機会
  • ステントの設計、材料、製造プロセスにおける継続的な進歩
  • 医療サービスや技術へのアクセスの拡大と相まってヘルスケア支出の増加
• 市場の課題
  • ステント留置の困難と合併症

ポーターのファイブフォース：ベアメタルステント市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ベアメタルステント市場における外部からの影響の把握

外部マクロ環境要因は、ベアメタルステント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ベアメタルステント市場における競合情勢の把握

ベアメタルステント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスベアメタルステント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ベアメタルステント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ベアメタルステント市場における成功への道筋を描く

ベアメタルステント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で心血管疾患（CVD）の発生率が上昇
    • 低侵襲手術への関心が高まる
  • 抑制要因
    • 市場における代替治療の入手可能性
  • 機会
    • ステントの設計、材料、製造プロセスの継続的な進歩
    • ヘルスケア費の増加と医療サービスや技術へのアクセスの拡大
  • 課題
    • ステント留置の困難さと合併症
• 市場セグメンテーション分析
  • 製品：心臓および末梢血管の医療処置におけるバルーンカテーテルおよび金属ステントの利用
  • エンドユーザー：病院での緊急介入や術後回復のためのベアメタルステントの使用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ベアメタルステント市場：製品別

• バルーンカテーテル
• バルーンエクスペンダブルステント
• 金属ステント
• 自己消耗型

第7章 ベアメタルステント市場：エンドユーザー別

• 外来手術センター
• 心臓カテーテル検査室
• 病院

第8章 南北アメリカのベアメタルステント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のベアメタルステント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのベアメタルステント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • FDAがボストンサイエンティフィックのAGENT薬剤コーティングバルーンを承認、末梢動脈疾患の治療を強化
  • カネカ、JMDT社の買収によりステント開発能力を強化
  • FDA、メディノールの革新的な薬剤溶出冠動脈ステントを承認
• 戦略分析と提言

企業一覧

• Abott Laboratories
• ACE CARDIOPATHY
• B. Braun SE
• Becton, Dickinson and Company
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• Cook Group Incorporated
• Medtronic PLC
• MeKo Manufacturing e.K.
• Meril Life Sciences Pvt Ltd.
• MicroPort Scientific Corporation
• Relisys Medical Devices Limited
• SLTL Group
• STENTYS SA
• Stryker Corporation
• Terumo Corporation
• Translumina Therapeutics

LIST OF FIGURES

• FIGURE 1. BARE-METAL STENTS MARKET RESEARCH PROCESS
• FIGURE 2. BARE-METAL STENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BARE-METAL STENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BARE-METAL STENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BARE-METAL STENTS MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BARE-METAL STENTS MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BARE-METAL STENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BARE-METAL STENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BARE-METAL STENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BARE-METAL STENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BARE-METAL STENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BARE-METAL STENTS MARKET DYNAMICS
• TABLE 7. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BALLOON CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BALLOON EXPENDABLE STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BARE-METAL STENTS MARKET SIZE, BY METALLIC STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SELF-EXPENDABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BARE-METAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 23. CANADA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. CANADA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 35. CHINA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. CHINA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 37. INDIA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDIA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 72. ITALY BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. ITALY BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 80. POLAND BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. POLAND BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 82. QATAR BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. QATAR BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM BARE-METAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM BARE-METAL STENTS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 102. BARE-METAL STENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. BARE-METAL STENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Bare-metal Stents Market was valued at USD 6.23 billion in 2023, expected to reach USD 6.57 billion in 2024, and is projected to grow at a CAGR of 5.66%, to USD 9.17 billion by 2030.

Bare-metal stents are medical devices used to treat narrowed or blocked coronary arteries in patients with coronary artery disease. They serve as a scaffold to combat artery closure post-angioplasty, enhancing blood flow and preventing restenosis. The necessity and application of bare-metal stents are pivotal in an aging population with increasing cases of cardiovascular ailments, often characterized by their reduced cost and specific suitability in patients who are unable to undergo prolonged dual antiplatelet therapy. End-use spans across hospitals, ambulatory surgical centers, and cardiac catheterization laboratories, where these stents are preferred due to their immediate availability and ease of insertion compared to drug-eluting alternatives. Influential growth drivers include expanding healthcare infrastructure, rising geriatric demographics, and increasing incidences of heart-related disorders across the globe. Opportunities in the market lie in refining stent materials to enhance flexibility and reduce thrombosis rates, along with geographical expansion in emerging markets where healthcare systems are rapidly improving. To exploit these opportunities, firms can focus on developing cost-effective stent models and investing in R&D for improved clinical outcomes. However, challenges persist in stringent regulatory approvals and the growing popularity of drug-eluting stents that offer lower restenosis rates, potentially overshadowing bare-metal variants. Market participants can drive innovation by focusing on biodegradable materials and hybrid stent designs that combine the benefits of both bare-metal and drug-eluting constructs. Moreover, leveraging advanced manufacturing techniques like 3D printing can foster customization and precision in stent deployment. The market's competitive nature underscores the importance of strategic partnerships and pursuing rigorous clinical trials to enhance product credibility and acceptance. Overall, substantial business growth can be achieved through innovation in materials and global market penetration initiatives while navigating regulatory landscapes effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bare-metal Stents Market

The Bare-metal Stents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of cardiovascular diseases (CVDs) globally
  • Increasing preference for minimally invasive procedures
• Market Restraints
  • Availability of alternative treatment in the market
• Market Opportunities
  • Ongoing advancements in stent design, materials, and manufacturing processes
  • Rising healthcare expenditure, coupled with expanding access to medical services and technologies
• Market Challenges
  • Difficulties and complications with stent implantation

Porter's Five Forces: A Strategic Tool for Navigating the Bare-metal Stents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bare-metal Stents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bare-metal Stents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bare-metal Stents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bare-metal Stents Market

A detailed market share analysis in the Bare-metal Stents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bare-metal Stents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bare-metal Stents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bare-metal Stents Market

A strategic analysis of the Bare-metal Stents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bare-metal Stents Market, highlighting leading vendors and their innovative profiles. These include Abott Laboratories, ACE CARDIOPATHY, B. Braun SE, Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Medtronic PLC, MeKo Manufacturing e.K., Meril Life Sciences Pvt Ltd., MicroPort Scientific Corporation, Relisys Medical Devices Limited, SLTL Group, STENTYS SA, Stryker Corporation, Terumo Corporation, and Translumina Therapeutics.

Market Segmentation & Coverage

This research report categorizes the Bare-metal Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Balloon Catheter, Balloon Expendable Stent, Metallic Stent, and Self-Expendable.
• Based on End Users, market is studied across Ambulatory Surgical Centers, Cardiac Catheterization Laboratories, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of cardiovascular diseases (CVDs) globally
    • 5.1.1.2. Increasing preference for minimally invasive procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of alternative treatment in the market
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in stent design, materials, and manufacturing processes
    • 5.1.3.2. Rising healthcare expenditure, coupled with expanding access to medical services and technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Difficulties and complications with stent implantation
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Utilization of balloon catheter and metallic stent in cardiac and peripheral vascular medical procedures
  • 5.2.2. End Users: Increasing usage of bare-metal stents in hospitals for emergency interventions and post-operative recovery
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bare-metal Stents Market, by Product

• 6.1. Introduction
• 6.2. Balloon Catheter
• 6.3. Balloon Expendable Stent
• 6.4. Metallic Stent
• 6.5. Self-Expendable

7. Bare-metal Stents Market, by End Users

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Cardiac Catheterization Laboratories
• 7.4. Hospitals

8. Americas Bare-metal Stents Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Bare-metal Stents Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Bare-metal Stents Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. FDA Approves Boston Scientific's AGENT Drug-Coated Balloon, Enhancing Peripheral Artery Disease Treatments
  • 11.3.2. Kaneka Corporation Enhances Stent Development Capabilities with Acquisition of JMDT
  • 11.3.3. FDA Greenlights Medinol's Innovative Drug-Eluting Coronary Stent
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abott Laboratories
• 2. ACE CARDIOPATHY
• 3. B. Braun SE
• 4. Becton, Dickinson and Company
• 5. BIOTRONIK SE & Co. KG
• 6. Boston Scientific Corporation
• 7. Cook Group Incorporated
• 8. Medtronic PLC
• 9. MeKo Manufacturing e.K.
• 10. Meril Life Sciences Pvt Ltd.
• 11. MicroPort Scientific Corporation
• 12. Relisys Medical Devices Limited
• 13. SLTL Group
• 14. STENTYS SA
• 15. Stryker Corporation
• 16. Terumo Corporation
• 17. Translumina Therapeutics